It is hypothesized that the local delivery of anti-inflammatory proteins by adoptive cellular gene therapy using retrovirally transduced type two collagen (CII)-specific T-cell hybridomas or autologous dendritic cells (DCs) in a murine model of rheumatoid arthritis (RA), collagen induced arthritis (CIA), will provide therapeutic effects. In addition, through the use of microarray technology, it will be possible to study changes in gene expression following successful therapy, leading to insights into the mechanisms of action of successful therapeutic regimens in this animal model and possible identification of new targets for immune intervention with potential use in human disease. This hypothesis will be explored through three specific aims:
SpecificAim #1 : To study the effects of combining IL-12p40 or IL-4 with anti-TNF or Gal-1 using local delivery of these molecules by adoptive cellular gene therapy using retrovirally transduced CII-specific T-cell hybridomas in CIA;
Specific Aim #2 : To use the retroviral vectors developed previously in our lab to transduce autologous DCs for adoptive cellular gene therapy and trafficking studies in vivo;
and Specific Aim #3 : To use cDNA microarray technology to assess gene expression patterns in treated versus untreated joints in an attempt to assess mechanism(s) of therapy in mice with CIA that were successfully treated by adoptivecellular gene therapy and to identify additional potential targets of therapy (molecules or pathways) through gene identification and characterization. It is hoped that these studies will allow transfer of the technology by adaptation of adoptive cellular gene therapy to human RA.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
2P01AI036535-09A1
Application #
6746104
Study Section
Special Emphasis Panel (ZAI1-NN-I (S1))
Project Start
2003-12-01
Project End
2008-11-30
Budget Start
2004-06-01
Budget End
2005-05-31
Support Year
9
Fiscal Year
2004
Total Cost
$296,921
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Samusik, Nikolay; Good, Zinaida; Spitzer, Matthew H et al. (2016) Automated mapping of phenotype space with single-cell data. Nat Methods 13:493-6
Spitzer, Matthew H; Nolan, Garry P (2016) Mass Cytometry: Single Cells, Many Features. Cell 165:780-91
Frei, Andreas P; Bava, Felice-Alessio; Zunder, Eli R et al. (2016) Highly multiplexed simultaneous detection of RNAs and proteins in single cells. Nat Methods 13:269-75
Angelo, Michael; Bendall, Sean C; Finck, Rachel et al. (2014) Multiplexed ion beam imaging of human breast tumors. Nat Med 20:436-42
Gottlieb, Peter; Utz, Paul J; Robinson, William et al. (2013) Clinical optimization of antigen specific modulation of type 1 diabetes with the plasmid DNA platform. Clin Immunol 149:297-306
O'Gorman, William E; Dooms, Hans; Thorne, Steve H et al. (2009) The initial phase of an immune response functions to activate regulatory T cells. J Immunol 183:332-9
Sachs, Karen; Itani, Solomon; Carlisle, Jennifer et al. (2009) Learning signaling network structures with sparsely distributed data. J Comput Biol 16:201-12
Creusot, Remi J; Yaghoubi, Shahriar S; Chang, Pearl et al. (2009) Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells. Blood 113:6638-47
Sachs, K; Itani, S; Fitzgerald, J et al. (2009) Learning cyclic signaling pathway structures while minimizing data requirements. Pac Symp Biocomput :63-74
Creusot, Remi J; Yaghoubi, Shahriar S; Kodama, Keiichi et al. (2008) Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice. Clin Immunol 127:176-87

Showing the most recent 10 out of 27 publications